MAY 07, 2018 10:00 AM EDT

Managing CMV Infection and Realizing Operational Efficiencies in your Laboratory

Speakers

Abstract

BROADCASTING on location at the Clinical Virology Symposium

Our first presenter, Dr. John McKinnon, will be presenting on:

CLINICAL IMPACT OF MISSING CMV VIREMIA IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS

Human cytomegalovirus (CMV) infection is prevalent in transplant patients, and is frequently associated with significant morbidity and mortality. In CMV positive recipients of allogeneic human stem cell transplantation, the incidence of viral reactivation can be seen in up to 80% of patients, with up to 30% of these patients ultimately developing clinically significant CMV disease.1 The potential clinical impact of missing CMV viremia cannot be understated. In the first part of this presentation, Dr. John McKinnon will present data from his study comparing two commercial assays for the quantitation of CMV and potential relationship with mutations on UL54.  

Learning Objectives:

  • Review of the current recommendations for CMV viral load monitoring in patients undergoing hematopoietic stem cell transplantation
  • Clinical study results of comparing two commercial assays for CMV viremia and genotypic resistance testing of samples with CMV viremia.
  • Clinical implications for our site and potential approaches to management of suspected CMV viremia.

Our second presenter, Dr. Frederick (Rick) Nolte, will be presenting on:

STREAMLINING AND STANDARDIZING MOLECULAR TESTING THROUGH CONSOLIDATION

Consolidation of laboratory testing on a single automated molecular platform can result in many benefits to the laboratory, namely by reducing the number of redundant instruments, streamlining operations, and standardizing testing – all of which may translate into considerable cost savings and improved operational efficiency. In the second part of this presentation, Dr. Rick Nolte presents his experience with consolidating IVDs and LDTs on a versatile molecular platform.

Learning Objectives:

  • Discuss the key factors to consider in selecting a molecular diagnostic test platform
  • Describe our experience with consolidation of LDTs and IVDs on the Abbott m2000 platform
  • Highlight the operational efficiencies that can be achieved through Lean laboratory design and the use of middleware in molecular diagnostic laboratories

 

1 J.E. McKinnon et al. Comparison of Roche and Abbott Cytomegalovirus Quantitative PCR Assays in Allogeneic Hematopoietic Cell Transplant Recipients. Poster presented at IDWeek, October 4-8, 2017, San Diego, CA


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
OCT 20, 2021 10:00 AM PDT
C.E. CREDITS
OCT 20, 2021 10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
JUN 22, 2021 10:00 AM PDT
C.E. CREDITS
JUN 22, 2021 10:00 AM PDT
Date: June 22, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Antimicrobial resistance (AMR) has emerged as one of the principal public health problems of the 21st century. It threatens the effectiv...
MAY 07, 2018 10:00 AM EDT

Managing CMV Infection and Realizing Operational Efficiencies in your Laboratory


Specialty

Laboratory Testing

Microbiology

Infectious Disease

Immunology

Clinical Diagnostics

Molecular Diagnostics

Clinical Chemistry

Molecular Biology

Biochemistry

Antibodies

Hematology

Virology

Cancer Research

Cancer Diagnostics

Diagnostics

Geography

North America77%

Asia10%

Europe9%

South America3%

Oceania1%

Africa1%

Registration Source

Website Visitors57%

Email Promotions26%

WAVE Newsletter Promotion16%

Website Banners1%

Social Media Promotions1%

Job Title

Medical Laboratory Technician28%

Clinical Laboratory Scientist13%

Lab Management11%

Facility/Department Manager10%

Medical Doctor/Specialist7%

Executive7%

Student6%

Research Scientist5%

Scientist4%

Educator/Faculty3%

Microbiologist2%

Chemist1%

QC/QA1%

Organization

Hospital26%

Clinical Laboratory21%

Medical Center9%

Academic Institution8%

Government4%

Biotech Company4%

Ambulatory Care3%

Research Institute3%

Medical Device Company2%

Medical School2%

Life Science Company2%

Non-Profit Organization1%

Pharmaceutical Company1%

Diagnostic Company1%

Other6%


Show Resources
Loading Comments...
Show Resources